Neurological Disorders and Treatments

When neurons are damaged by events like ischemic stroke or by the slow accumulation of misfolded proteins in Alzheimer's disease, the brain has a limited capacity to repair itself, making the window for intervention narrow and the consequences of failure severe. A central challenge is that injury often triggers a cascade of secondary harm — mitochondria lose their normal function, reactive oxygen species accumulate, and cells that survived the initial insult die in the hours and days that follow. Compounds like Citicoline and Cerebrolysin are being studied as neuroprotective agents that may interrupt these cascades, supporting membrane integrity and signaling pathways that keep neurons alive or encourage partial recovery. Active research is working to clarify exactly how these agents act at the molecular level, whether their benefits extend to chronic conditions like glaucoma and Alzheimer's disease, and how they might be combined with other therapies to produce effects that neither achieves alone.

Works

89,871

Total citations

296,259

Keywords

CiticolineCerebrolysinOxidative StressIschemic StrokeNeuroprotectionMitochondrial Dysfunction